Former Chief Medical Officer · Arcus Biosciences, Inc. (RCUS)

William Grossman

A named executive officer of Arcus Biosciences in every fiscal year CompBrief holds from FY2019 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,926,548

Salary $317,263Stock awards $688,688

FY2020: $6,134,970

4th of 6 named executive officers at Arcus Biosciences by FY2021 total.

6 named officers on file for Arcus Biosciences, FY2021

William Grossman’s pay file — $29

  • 3 fiscal years of pay, line by line
  • RCUS’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Arcus Biosciences’s whole pay program stands against its peers

  • Arcus Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RCUS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2022 (DEF 14A).

Free

Get William Grossman’s full pay file as a PDF — free

More than this page: up to 10 years of William’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

William Grossman compensation by year

Arcus Biosciences Summary Compensation Table · all 3 fiscal years held
In US dollars, as Arcus Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021
Salary$296,667$457,600$317,263
Bonus$200,000$0$0
Stock awards$0$3,352,750$688,688
Option awards$2,723,040$2,073,420$2,917,697
Non-equity incentive$180,000$250,000$0
Pension and deferred compensation$0$0$0
All other$600$1,200$2,900
Total$3,400,307$6,134,970$3,926,548

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcus Biosciences, Inc. DEF 14A filed April 20, 2022, accession 0000950170-22-005855, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Arcus Biosciences, Inc. filed document, accession 0000950170-22-005855. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2022.

$3.4M
$6.1M
$3.9M
FY19
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Arcus Biosciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Jennifer JarrettChief Operating Officer$15,520,200
Terry RosenChief Executive Officer$9,480,974
Juan Carlos JaenPresident and Director$4,412,919
William Grossman · this pageFormer Chief Medical Officer$3,926,548
Robert GoeltzChief Financial Officer$2,919,470
Carolyn TangGeneral Counsel$2,916,407

The full Arcus Biosciences compensation record

free company brief

This page is one person within Arcus Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Arcus Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arcus Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

William Grossman's compensation dossier · One-time report. No refunds.